1. Home
  2. FSP vs FLNA Comparison

FSP vs FLNA Comparison

Compare FSP & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Street Properties Corp.

FSP

Franklin Street Properties Corp.

HOLD

Current Price

$0.38

Market Cap

33.3M

Sector

Real Estate

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

SELL

Current Price

$0.64

Market Cap

30.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
FSP
FLNA
Founded
1981
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.3M
30.0M
IPO Year
2001
2000

Fundamental Metrics

Financial Performance
Metric
FSP
FLNA
Price
$0.38
$0.64
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $6.50
AVG Volume (30 Days)
★ 591.3K
462.6K
Earning Date
10-27-2026
11-05-2026
Dividend Yield
★ 2.66%
N/A
EPS Growth
★ 15.69
N/A
EPS
★ N/A
N/A
Revenue
★ $107,162,000.00
$41,119,000.00
Revenue This Year
$16.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.30
$0.39
52 Week High
$1.05
$2.03

Technical Indicators

Market Signals
Indicator
FSP
FLNA
Relative Strength Index (RSI) 44.11 55.81
Support Level $0.31 $0.43
Resistance Level $0.40 $0.68
Average True Range (ATR) 0.03 0.06
MACD -0.01 0.02
Stochastic Oscillator 9.57 93.03

Price Performance

Historical Comparison
FSP
FLNA

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: